Why Haemonetics Stock Rallied on Friday
A day after its stock took a 13% bath following the release of fourth-quarter results, Haemonetics (NYSE: HAE) bounced back on Friday. Several analysts tweaked their outlooks on the company, and it closed the day more than 8% higher.
Friday saw five financial services companies tracking Haemonetics stock adjust their views. The analysts at four of those five -- Morgan Stanley, JMP Securities, Needham & Company, Jefferies, and CJS Securities -- all lowered their price targets. Crucially, however, they maintained their recommendations, which were almost all buys or the equivalent thereof (Morgan Stanley maintained at equalweight).
Image source: Getty Images.
Source Fool.com
